CSF1R and myeloid sarcoma: Recently, Hagan and colleagues proposed that the CSF1R pathway could regulate MS, and to demonstrate their hypothesis they used a CSF1R inhibitor on primary murine microglia to study its impact on the proliferation and production of pro-inflammatory molecules.